Sigyn Therapeutics, Inc.
SIGY
$2.76
-$0.99-26.40%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -68.27% | 11.81% | 55.55% | -32.15% | -19.26% |
| Total Depreciation and Amortization | -100.00% | -6.67% | -62.16% | 1,500.00% | -46.15% |
| Total Amortization of Deferred Charges | -52.43% | -3.55% | -81.45% | 35.93% | -27.49% |
| Total Other Non-Cash Items | 2,320.27% | 33.33% | -13.91% | 738.11% | 121.92% |
| Change in Net Operating Assets | -29.79% | -43.75% | -69.18% | 56.90% | 85.56% |
| Cash from Operations | 16.63% | -24.96% | -126.90% | 55.00% | 44.39% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -38.76% | 6.65% | 141.33% | -25.56% | 662.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -31.24% | 14.95% | 83.47% | -32.10% | 578.67% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -159.62% | -96.21% | -188.47% | 170.98% | 106.96% |